Orbis Medicines

Orbis Medicines is a biotechnology company focused on ushering in a new era of oral macrocycle drug discovery. Macrocycles represent a large and diverse family of compounds with highly desirable therapeutic properties, defined by the presence of a cyclic structure. Orbis Medicines' nGen platform is designed to systematically explore macrocycle chemical space using a highly automated chemistry platform, delivering orally available macrocycle candidates, nCycles, suitable for both intracellular and extracellular targets. Orbis Medicines’ programs are centered on high-value oral alternatives to blockbuster biologics, as well as challenging targets beyond existing modalities.